Tag: pharmaceuticals
-
Trial to Assess Anti-Gravity Treadmill for Stress Test
Researchers at University of Cincinnati Medical Center plan to evaluate an anti-gravity treadmill for cardiac stress tests that check for heart disease.
-
Portable On-Demand Biologic Production System Designed
A device that produces small batches of biological drugs, down to a single dose, was shown to generate two different biopharmaceuticals under lab conditions.
-
Open-Source Discovery Yields Anti-Malaria Candidates
A worldwide research project tested 400 compounds as anti-malarial drugs, which led to more than 30 new drug development programs for malaria and other diseases.
-
Gene Therapy Designed for Muscle Wasting Disease
Researchers devised a treatment for a cancer-related muscle wasting disease using gene transfers that in lab mice block signals promoting muscle degradation.
-
Trial Underway Testing Stem Cells to Treat Alzheimer’s
An intermediate-stage clinical trial is recruiting participants to test donated stem cells as a treatment for mild-moderate dementia from Alzheimer’s disease.
-
Nanoparticles, Peroxide Boost Tooth Decay Prevention
Adding iron oxide nanoparticles to hydrogen peroxide is shown to reduce the build-up of bacterial films on teeth, preventing cavities from forming in lab rats.
-
Patch Delivers Gene, Drug, Heat Therapies to Colon Tumors
Engineers developed a hydrogel patch with three types of therapy applied directly to tumors in the colon, which in lab mice caused cancer to go into remission.
-
Microneedle System Designed for Drug Monitoring
Researchers designed a device that measures drug concentrations in patients with tiny microneedles on the skin rather than frequent invasive blood tests.
-
Common Antibodies Found for Multi-Virus Flu Vaccine
A team at National Institutes of Health discovered three types of antibodies that can neutralize a variety of influenza viral strains infecting humans.
-
Genetic Disease Biotech Gains $55M in Early Funds
A biotechnology start-up developing therapies for genetic diseases through regulation of genetic processes is raising $55 million in its first venture round.